China Traditional Chinese Medicine Co., Ltd. - B (01672.HK) will increase the funds for repurchasing shares from a maximum of 300 million Hong Kong dollars to a maximum of 500 million Hong Kong dollars.

Smart Finance APP News, GeLi Pharmaceutical-B (01672.HK) announced that the board of directors believes that the current stock price of the company is undervalued. Therefore, on December 15, 2025, the board of directors decided to increase the funds for share repurchase from up to 300 million Hong Kong dollars to up to 500 million Hong Kong dollars.